Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects.pdf
thepharmacokinetics,pharmacodynamics,safetyand tolerability apixabaninhealthy subjectsCorrespondence
apixaban for the prophylaxis and on treatment of deep vein thrombosis and pulmonary embolism an evidence-based review.pdf
2015Mandernach et al. DoveMedical Press Limited, licensedunder Creative Commons Attribution NonComme
Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin.pdf
FullLength ArticleCancer cells BXPC3 MCF7differentially reverse inhibitionofthrombin generation apix
Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands.pdf
Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands
An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison Centers.pdf
ObservationalStudy FactorXa Inhibitors Rivaroxabanand Apixaban EightPoison CentersHenry Spiller,MS,
Center punch and whole spot bioanalysis of apixaban in human dried blood spot samples by UHPLC-MSMS.pdf
988(2015) 66–74Contents lists available ChromatographyBj ou alhom epage: www. el sevi er chromb“Cent
importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban.pdf
PharmacokineticProfile VariabilityasDeterminants Gong,BMSc,a,band Richard Kim,MDa,baDivision Clinical
Apixaban, an oral, direct factor Xa inhibitor single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects.pdf
oral,directfactor Xa inhibitor: singledose safety,pharmacokinetics,pharmacodynamics healthysubjectsC
Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation A Systematic Review and Meta-Analysis of Subgroups.pdf
HndwPshn CopotonTomossVom 2013, ID640723, 18 pshttp://dx.do.o/10.1155/2013/640723Review ArticleDabig
Apixaban (BMS 562247-01)-cas-503612-47-3-datasheet-DC Chemicals.pdf
Apixaban (BMS 562247-01)-cas-503612-47-3-datasheet-DC Chemicals